References
- Bajuk V, Leskovec NK, Ručigaj TP, Suhodolčan AB, Dolenc-Voljč M. Toenail alterations in chronic venous disease patients are not always of mycotic origin. Phlebology. 2019;34(6):421-6.
- Shemer A, Nathanson H, Kaplan B, Trau H. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat? J Eur Acad Dermatol Venereol. 2008;22(3):279-82.
- Sáez de Ocariz MM, Arenas R, Ranero-Juárez GA, Farrera-Esponda F, Monroy-Ramos E. Frequency of toenail onychomycosis in patients with cutaneous manifestations of chronic venous insufficiency. Int J Dermatol. 2001;40(1):18-25.
- Cañete-Gibas C, Wiederhold NP. Mycology of onychomycosis. Clin Microbiol Newsl. 2023;45(2):11-7.
- Piraccini BM, Starace M, Rubin AI, Di Chiacchio NG, Iorizzo M, Rigopoulos D. Onychomycosis: recommendations for diagnosis, assessment of treatment efficacy, and specialist referral. The CONSONANCE consensus project. Dermatol Ther (Heidelb). 2022; 12 (4):885-98.
- Lipner SR, Scher RK. Onychomycosis: clinical overview and diagnosis. J Am Acad Dermatol. 2019; 80-(4):835-51.
- Falotico JM, Lipner SR. Updated perspectives on the diagnosis and management of onychomycosis. Clin Cosmet Investig Dermatol. 2022;15:1933-57.
- Leung AKC, Lam JM, Leong KF, Hon KL, Barankin B, Leung AAM, et al. Onychomycosis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):32-45.
- Gupta A, Stec N, Summerbell RC, Shear NH, Piguet V, Tosti A, et al. Onychomycosis: a review. J Eur Acad Dermatol Venereol. 2020;34(9):1972-90.
- Gupta AK, Wang T, Polla Ravi S, Mann A, Bamimore MA. Global prevalence of onychomycosis in general and special populations: an updated perspective. Mycoses. 2024;67(4):e13725.
- Gupta AK, Elewski B, Joseph WS, Lipner SR, Daniel CR, Tosti A, et al. Treatment of onychomycosis in an era of antifungal resistance: role for antifungal stew-ardship and topical antifungal agents. Mycoses. 2024;67(1):e13683.
- Van der Weerden NL, Parisi K, McKenna JA, Hayes BM, Harvey PJ, Quimbar P, et al. The plant defensin Ppdef1 is a novel topical treatment for onychomycosis. J Fungi (Basel). 2023;9(11):1111.
- Kulac M, Acar M, Karaca S, Cetinkaya Z, Albayrak R, Haktanir A, et al. Venous insufficiency in patients with toenail onychomycosis. J Ultrasound Med. 2005;24(8):1085-9.
- Cabete J, Galhardas C, Apetato M, Lestre S. Onychomycosis in patients with chronic leg ulcer and toenail abnormalities. An Bras Dermatol. 2015;90 (1):136-9.
- Albucker SJ, Falotico JM, Choo ZN, Matushansky JT, Lipner SR. Risk factors and treatment trends for onychomycosis: a case–control study of onychomycosis patients in the All of Us Research Program. J Fungi (Basel). 2023;9(7):712.
- Yousefian F, Smythe C, Han H, Elewski BE, Nestor M. Treatment options for onychomycosis: Eefficacy, side effects, adherence, financial considerations, and ethics. J Clin Aesthet Dermatol. 2024;17(3):24-33.
- Gregoriou S, Kyriazopoulou M, Tsiogka A, Rigopoulos D. Novel and investigational treatments for onychomycosis. J Fungi (Basel). 2022;8(10):1079.
- Moreno-Coutiño G, Sandoval-Navarro K, Lozano-Platonoff A, Toussaint-Caire S, Vega-Sánchez D. Chronic venous insufficiency associated to sub-clinical onychomycosis. International Journal of Dermatology Research. 2023;5(1):17-20.
- Lipner SR, Scher RK. Onychomycosis: treatment and prevention of recurrence. J Am Acad Dermatol. 2019;80(4):853-67.
- Bang CH, Yoon JW, Lee HJ, Lee JY, Park YM, Lee SJ, et al. Evaluation of relationships between onychomycosis and vascular diseases using sequential pattern mining. Sci Rep. 2018;8(1):17840.
- Watjer RM, Heckmans KM, Eekhof JA, Gummi L, Quint KD, Numans ME, et al. Association between onychomycosis and ulcerative complications in patients with diabetes: a longitudinal cohort study in Dutch general practice. BMJ Open. 2024;14(4):e076441.
- Rossboth S, Rossboth B, Schoenherr H, Lechleitner M, Oberaigner W. Risk factors for diabetic foot complications among patients with type 2 diabetes in Austria-a registry-based retrospective cohort study. Endocrinol Diabetes Metab. 2021;4(4):e00286.
- Haneke E. Onychomycosis in foot and toe malformations. J Fungi (Basel). 2024;10(6):399.
- Papini M, Cicoletti M, Fabrizi V, Landucci P. Skin and nail mycoses in patients with diabetic foot. G Ital Dermatol Venereol. 2013;148(6):603-8.
- Shah KV, Desai AD, Lipner SR. Retrospective analysis of onychomycosis risk factors using the 2003-2014 National Inpatient Sample. Dermatol Pract Concept. 2024;14(2):e2024074.
- Buttars B, Scott SG, Glinka D, Daniel CR, Brodell RT, Braswell MA. Congenital malalignment of the great toenail, the disappearing nail bed, and distal phalanx deviation: a review. Skin Appendage Disord. 2022;8(1):8-12.
- Kılınç F, Akbaş A, Şener S, Hayran Y, Aktaş A. Cutaneous findings in patients with chronic venous insufficiency. J Cosmet Dermatol. 2022;21(5):2106-12.
- Lipner SR, Scher RK. Evaluation of nail lines: color and shape hold clues. Cleve Clin J Med. 2016;83 (5): 385-91.
- Falotico JM, Lapides R, Lipner SR. Combination therapy should be reserved as second-line treatment of onychomycosis: a systematic review of onychomycosis clinical trials. J Fungi (Basel). 2022; 8 (3) :279.
- Stalević M, Ignjatović A, Randjelović M, Otašević S. Risk factors and cluster analysis of onychomycosis. Acta Medica Medianae. 2023;62(4):29-36.
- Gupta AK, Mays RR, Versteeg SG, Shear NH, Piguet V. Update on current approaches to diagnosis and treatment of onychomycosis. Expert Rev Anti Infect Ther. 2018;16(12):929-38.
- Lim SS, Ohn J, Mun JH. Diagnosis of onychomycosis: from conventional techniques and dermoscopy to artificial intelligence. Front Med (Lausanne). 2021; 8:637216.
- Yorulmaz A, Yalcin B. Dermoscopy as a first step in the diagnosis of onychomycosis. Postepy Dermatol Alergol. 2018;35(3):251-8.
- Mahajan K, Grover C, Relhan V, Tahiliani S, Singal A, Shenoy MM, et al. Nail Society of India recommendations for treatment of onychomycosis in special population groups. Indian Dermatol Online J. 2024;15(2):196-204.
- Kim JK, Chung HC, Chun EJ, Kim S, Kim CW. Correlation between nail thickness and onychomycosis: Misuse of antifungal agents in patients with thick nails. Ann. Dermatol. 2024;36(2):123-4.
- Haneke E. Differential diagnosis of nail psoriasis and onychomycoses: a report based on 40 years of specialised nail consultations. EMJ Dermatol. 2020:00008. httsp://doi.org/10.33590/emj der ma tol /20-00008
- Aldana-Caballero A, Mayordomo R, Marcos-Tejedor F. Assessment of visual diagnosis by podiatrists for HPV and onychomycosis: the need for complementary tests. J Fungi (Basel). 2022;8(2):135.
- Hay RJ. The spread of resistant tinea and the ingredients of a perfect storm. Dermatology. 2022; 238-(1):80-1.
- Dhamoon RK, Popli H, Gupta M. Novel drug delivery strategies for the treatment of onychomycosis. Pharm Nanotechnol. 2019;7(1):24-38.
- Gupta AK, Stec N. Emerging drugs for the treatment of onychomycosis. Expert Opin Emerg Drugs. 2019;-24(4):213-20.
- Aslam R, Hussain T, Yousaf AM, Ghori MU, Khan IU, Rizvi SAA, et al. Onychomycosis: current understanding and strategies for enhancing drug delivery into human nail tissue. Curr Drug Res Rev. 2021; 13 (1):25-35.
- Wang Y, Lipner SR. Retrospective analysis of adverse events with systemic onychomycosis medications reported to the United States Food and Drug Administration. J Dermatolog Treat. 2021;32(7):783-7.
- Ricardo JW, Lipner SR. Safety of current therapies for onychomycosis. Expert Opin Drug Saf. 2020; 19(11):1395-408.
- Gupta AK, Stec N, Bamimore MA, Foley KA, Shear NH, Piguet V. The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis. J Eur Acad Dermatol Venereol. 2020;34 (3):580-8.
- Gupta AK, Foley KA, Mays RR, Shear NH, Piguet V. Monotherapy for toenail onychomycosis: a systematic review and network meta-analysis. Br J Dermatol 2020;182(2):287-99.
- El-Tatawy RA, Aliweh HA, Hegab DS, Talaat RAZ, Shams Eldeen MA. Fractional carbon dioxide laser and topical tioconazole in the treatment of fingernail onychomycosis. Lasers Med Sci. 2019;34(9):1873-80.